r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

GO

Gilmore Neil O'Neill

Insider · CEO · EDIT

Gilmore Neil O'Neill files insider transactions with the SEC as a ceo of Editas Medicine (EDIT). We hold 3 disclosed purchases and sales filed since 11 June 2018, 1 of them in the last 90 days.

  • Files forEDIT
  • Disclosed buys and sells3 in all, 1 in the last 90 days
  • Last disclosure4 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 2 June 2022 — 3 September 2026CEO · Editas Medicine (EDIT)25 Form 4 lines · source: SEC Form 4
  • Filed 10 December 2020 — 21 June 2024Director · Unity Biotechnology (UBX)5 Form 4 lines · source: SEC Form 4
  • Filed 19 October 2021 — 26 May 2022Director · Aptinyx (APTX)2 Form 4 lines · source: SEC Form 4
  • Filed 7 June 2018 — 3 March 2021EVP, R&D & Cmo · Sarepta Therapeutics (SRPT)12 Form 4 lines · source: SEC Form 4

Everything they disclosed

44 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.